Clonal groups of uropatogenic escherichia coli isolated in the russian federation in 2004–2019
- Autores: Slukin P.V.1, Fursova N.K.1, Svetoch E.A.1, Perepanova T.S.2, Ershova M.G.3, Poletaeva E.D.3, Kruglov A.N.4, Priputnevich T.V.5
-
Afiliações:
- State Scientific Center for Applied Microbiology and Biotechnology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
- N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology – Branch of the National Medical Research Radiological Center, Ministry of Health of Russia
- Infectious Clinical Hospital № 1
- Moscow Multidisciplinary Clinical Center «Kommunarka» of the Moscow Healthcare Department
- Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
- Edição: Volume 14, Nº 1 (2024)
- Páginas: 55-61
- Seção: Original Investigations
- URL: https://journals.eco-vector.com/2226-6976/article/view/630519
- DOI: https://doi.org/10.18565/epidem.2024.14.1.55–61
- ID: 630519
Citar
Texto integral



Resumo
Objective. Identification and characteristics of clonal groups of E. coli isolated from patients with urinary tract infections in the Russian Federation in 2004–2019.
Materials and methods. E. coli strains (n = 303) isolated in 2004–2019 from urine samples of patients with urological diagnoses. The microbiological, molecular genetic and bioinformatic methods for assessing resistance and virulence, as well as molecular genetic methods for identifying phylogenetic groups, O-groups and sequence types were used in the study.
Results. The widespread distribution of uropathogenic strains of the O25-B2-ST131 clonal group in Russia has been shown; in addition, O2-B2-ST141, O89-A-ST744, O4/O6-B2-ST127, B1-ST58, D-ST69, O2/O6-B2-ST73, A-CC10 and O75-B2-CC14clonal groups have been identified.
Conclusion. Assessing the distribution of clonal groups of uropathogenic strains in Russia allows to assess the epidemic situation, predict its development in the future, and also determine the optimal directions of therapy.
Palavras-chave
Texto integral

Sobre autores
Pavel Slukin
State Scientific Center for Applied Microbiology and Biotechnology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Autor responsável pela correspondência
Email: xopgi@yandex.ru
ORCID ID: 0000-0002-4976-0145
Researcher, Department of Molecular Microbiology
Rússia, Obolensk, Moscow RegionNadezhda Fursova
State Scientific Center for Applied Microbiology and Biotechnology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: n-fursova@yandex.ru
ORCID ID: 0000-0001-6053-2621
Cand. Biol. Sci., Leading Researcher, Department of Molecular Microbiology
Rússia, Obolensk, Moscow RegionEduard Svetoch
State Scientific Center for Applied Microbiology and Biotechnology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: svetoch@obolensk.org
ORCID ID: 0000-0002-3185-1954
DVSc, Professor, Chief Researcher, Department of Molecular Microbiology
Rússia, Obolensk, Moscow RegionTamara Perepanova
N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology – Branch of the National Medical Research Radiological Center, Ministry of Health of Russia
Email: perepanova2003@mail.ru
МD, Professor, Head, Group of Infectious and Inflammatory Diseases and Clinical Pharmacology
Rússia, MoscowMarina Ershova
Infectious Clinical Hospital № 1
Email: mary.erschowa2013@yandex.ru
ORCID ID: 0000-0003-4691-648X
Head, Microbiological Laboratory
Rússia, YaroslavlElena Poletaeva
Infectious Clinical Hospital № 1
Email: mary.erschowa2013@yandex.ru
ORCID ID: 0000-0002-7074-6989
Bacteriologist
Rússia, YaroslavlAleksandr Kruglov
Moscow Multidisciplinary Clinical Center «Kommunarka» of the Moscow Healthcare Department
Email: kruglov_a_n@mail.ru
ORCID ID: 0000-0001-6849-0008
Cand. Biol. Sci., Senior Researcher, Head, Laboratory of Clinical Microbiology
Rússia, MoscowTatyana Priputnevich
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: t_priputnevich@oparina4.ru
ORCID ID: 0000-0002-4126-9730
Professor, Corresponding Member of the Russian Academy of Sciences, МD, Director
Rússia, MoscowBibliografia
- Кузнецова М.В., Проворова С.В., Кубарев О.Г., Юдин Д.П., Каримова Н.В., Баяндина Н.В. и др. Сравнительная характеристика штаммов уропатогенной Escherichia coli, выделенных в условиях поликлиники и стационара. Урология 2018; (6): 37–44. doi: 10.18565/urology.2018.6.37-44
- Kuznetsova M.V., Provorova S.V., Kubarev O.G., Yudin D.S., Karimova N.V., Bajandina N.V. et al. [Comparative characteristics of uropathogenic Escherichia coli strains, allocated in polyclinic and stationary conditions]. Urologiia 2018; (6): 37–44. (In Russ.). doi: 10.18565/urology.2018.6.37-44
- Javed S., Mirani Z.A., Pirzada Z.A. Phylogenetic group B2 expressed significant biofilm formation among drug resistant uropathogenic Escherichia coli. Libyan J. Med. 2021; 16(1): 1845444. doi: 10.1080/19932820.2020.1845444
- Zhong Z.X., Cui Z.H., Li X.J., Tang T., Zheng Z.J., Ni W.N. et al. Nitrofurantoin combined with amikacin: a promising alternative strategy for combating MDR uropathogenic Escherichia coli. Front Cell Infect. Microbiol. 2020; (10): 608547. doi: 10.3389/fcimb.2020.608547
- Magiorakos A.P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G. et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 2012; 18(3): 268–81. doi: 10.1111/j.1469-0691.2011.03570.x
- Naziri Z., Derakhshandeh A., Soltani Borchaloee A., Poormaleknia M., Azimzadeh N. Treatment failure in urinary tract infections: a warning witness for virulent multi-drug resistant ESBL-producing Escherichia coli. Infect. Drug. Resist. 2020; 13: 1839–50. doi: 10.2147/IDR.S256131
- Manges A.R., Johnson J.R. Reservoirs of extraintestinal pathogenic Escherichia coli. Microbiol. Spectr. 2015; 3(5): 10.1128/microbiolspec.UTI-0006-2012. doi: 10.1128/microbiolspec.UTI-0006-2012
- Flament-Simon S.C., Toro M., García V., Blanco J.E., Blanco M., Alonso M.P. et al. Molecular characteristics of extraintestinal pathogenic E. coli (ExPEC), uropathogenic E. coli (UPEC), and multidrug resistant E. coli isolated from healthy dogs in Spain. Whole Genome Sequencing of Canine ST372 Isolates and Comparison with Human Isolates Causing Extraintestinal Infections. Microorganisms 2020; 8(11): 1712. doi: 10.3390/microorganisms8111712
- Nüesch-Inderbinen M.T., Baschera M., Zurfluh K., Hächler H., Nüesch H., Stephan R. Clonal diversity, virulence potential and antimicrobial resistance of Escherichia coli causing community acquired urinary tract infection in Switzerland. Front. Microbiol. 2017; (8): 2334. doi: 10.3389/fmicb.2017.02334
- Hojabri Z., Mirmohammadkhani M., Darabi N., Arab M., Pajand O. Characterization of antibiotic-susceptibility patterns and virulence genes of five major sequence types of Escherichia coli isolates cultured from extraintestinal specimens: a 1-year surveillance study from Iran. Infect. Drug. Resist. 2019; (12): 893–903. doi: 10.2147/IDR.S199759
- Shahbazi R., Salmanzadeh-Ahrabi S., Aslani M.M., Alebouyeh M., Falahi J., Nikbin V.S. The genotypic and phenotypic characteristics contributing to high virulence and antibiotics resistance in Escherichia coli O25-B2-ST131 in comparison to non-O25-B2-ST131. BMC Pediatr. 2023; 23(1): 59. doi: 10.1186/s12887-023-03866-w
- Kuzina E.S., Astashkin E.I., Lev A.I., Ageeva E.N., Kartsev N.N., Svetoch E.A. et al. Class 1 and 2 Integrons in Hospital Strains of Gram-Negative Bacteria Isolated in Moscow and in Regions of the Russian Federation. Molecular Genetics, Microbiology and Virology 2019; 34(1): 16–24. doi: 10.3103/S0891416819010051
- Казанцев А.В., Осина Н.А., Глинская Т.О., Кошелева О.Н., Максимов Ю.В., Девдариани З.Л. и др. Факторы вирулентности и филогенетическая характеристика уропатогенных штаммов Escherichia coli, выделенных на территории г. Саратова. Проблемы особо опасных инфекций; 2019: (4): 56–60. doi: 10.21055/0370-1069-2019-4-56-60
- Kazantsev A.V., Osina N.A., Glinskaya T.O., Kosheleva O.N., Maksimov Yu.V., Devdariani Z.L. et al. [Virulence factors and phylogenetic characteristics of uropathogenic Eschericihia coli strains isolated in Saratov]. Problems of Particularly Dangerous Infections; 2019: (4): 56–60. (In Russ.) doi: 10.21055/0370-1069-2019-4-56-60
- Iguchi A., Iyoda S., Seto K., Morita-Ishihara T., Scheutz F., Ohnishi M. Pathogenic E. coli working group in Japan. Escherichia coli O-genotyping PCR: a comprehensive and practical platform for molecular O serogrouping. J. Clin. Microbiol. 2015; 53(8): 2427–32. doi: 10.1128/JCM.00321-15
- Clermont O., Christenson J.K., Denamur E., Gordon D.M. The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environ Microbiol. Rep. 2013; 5(1): 58–65. doi: 10.1111/1758-2229.12019
- Alikhan N.F., Zhou Z., Sergeant M.J., Achtman M. A genomic overview of the population structure of Salmonella. PLoS Genet. 2018; 14(4): e1007261. doi: 10.1371/journal.pgen.1007261
- Ny S., Edquist P., Dumpis U., Gröndahl-Yli-Hannuksela K., Hermes J., Kling A.M. et al. Аntimicrobial resistance of Escherichia coli isolates from outpatient urinary tract infections in women in six European countries including Russia. J. Glob. Antimicrob. Resist. 2019; 17: 25–34. doi: 10.1016/j.jgar.2018.11.004
- Platell J.L., Trott D.J., Johnson J.R., Heisig P., Heisig A., Clabots C.R. et al. Prominence of an O75 clonal group (clonal complex 14) among non-ST131 fluoroquinolone-resistant Escherichia coli causing extraintestinal infections in humans and dogs in Australia. Antimicrob. Agents Chemother. 2012; 56(7): 3898–904. doi: 10.1128/AAC.06120-11
- Gati N.S., Middendorf-Bauchart B., Bletz S., Dobrindt U., Mellmann A. Origin and evolution of hybrid shiga toxin-producing and uropathogenic Escherichia coli strains of sequence type 141. J. Clin. Microbiol. 2019; 58(1): e01309–19. doi: 10.1128/JCM.01309-19
- Reid C.J., Blau K., Jechalke S., Smalla K., Djordjevic S.P. Whole genome sequencing of Escherichia coli from store-bought produce. Front Microbiol. 2020; 10: 3050. doi: 10.3389/fmicb.2019.03050
- Halaji M., Shahidi S., Ataei B., Atapour A., Feizi A., Havaei S.A. Molecular epidemiology of blaCTX-M gene-producing uropathogenic Escherichia coli among Iranian kidney transplant patients: clonal dissemination of CC131 and CC10. Ann. Clin. Microbiol. Antimicrob. 2021; 20(1): 65. doi: 10.1186/s12941-021-00470-7
- Riley L.W. Pandemic lineages of extraintestinal pathogenic Escherichia coli. Clin. Microbiol. Infect. 2014; 20(5): 380–90. doi: 10.1111/1469-0691.12646
- Kubelová M., Koláčková I., Gelbíčová T., Florianová M., Kalová A., Karpíšková R. Virulence properties of mcr-1-positive Escherichia coli isolated from retail poultry meat. Microorganisms 2021; 9(2): 308. doi: 10.3390/microorganisms9020308
Arquivos suplementares
